QualityStocksNewsBreaks – CytoDyn Inc. (CYDY) President and CEO Discusses Company Research in Interview on Uptick Newswire’s “Stock Day” Podcast
Biotechnology company CytoDyn (OTCQB: CYDY) this morning announced that the company’s president and CEO Nader Pourhassan was interviewed on Uptick Newswire’s “Stock Day” Podcast. Among other highlights, Pourhassan discussed the company’s main product, a humanized monoclonal antibody, which has demonstrated positive results in HIV patients in a human clinical trial. The antibody has received fast-track designation with the FDA, with the potential of approval in early 2019. In addition, Pourhassan discussed a letter of intent and acquisition of a company with advanced cancer treatment and the company’s newly-hired board member, Michael Klump. To listen to the full interview, visit http://ibn.fm/4qSie…